The environmental risk factors in multiple sclerosis susceptibility: A case-control study

Authors
Vahid Shaygannejad 1
Nooshin Rezaie 2
Zamzam Paknahad 3
Freshteh Ashtari 1
Helia Maghzi 2
1 Isfahan Neurosciences Research Center, Alzahra Hospital, Isfahan; Department of Neurology, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran
2 Isfahan Neurosciences Research Center, Alzahra Hospital, Isfahan, Iran
3 Department of Clinical Nutrition, School of Nutrition and Food Sciences, Isfahan, Iran
Abstract
Background: Multiple sclerosis (MS) is a demyelinating and degenerating disease which involves central nervous system. Environmental risk factors have a key role in MS susceptibility. Here we aim to investigate different risk factors effect on MS susceptibility in a large population of MS patients in Isfahan, Iran.
Materials and Methods: This study is a cross-sectional hospital-based study, which was conducted on a large group of MS patients registered in Kashani hospital and a control group from normal healthy population. Demographic data, age at onset of the disease, history of viral infections, vaccination, history of trauma to head, recent stressful events, alimentation, familial history, method of delivery (caesarean section, normal vaginal delivery), disability score and history of smoking were gathered using a designed questionnaire.




Results: Totally 536 MS patient with the mean age of 34.37 ± 9.22 and 399 individuals from healthy population with the mean age of 32.53 ± 9.91 were recruited. Significant difference in history of measles infection (control = 15.5%, case = 22.4%, P = 0.009), consumption of dairy products (case = 56.6%, control = 67.5%, P = 0.01) and major stressful life events (case = 62.2%, control = 52.7%, P < 0.05) between these two groups were demonstrated.
Conclusion: A significant relation between stress, history of infection and milk consumption was reached that highlights the importance of environmental risk factors in MS pathogenesis.

Keywords

1.
Harris MK, Maghzi AH, Etemadifar M, Kelley RE, Gonzalez-Toledo E, Minagar A. Acute demyelinating disorders of the central nervous system. Curr Treat Options Neurol 2009;11:55-63.  Back to cited text no. 1
[PUBMED]    
2.
Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: Risk factors, prodromes, and potential causal pathways. Lancet Neurol 2010;9:727-39.  Back to cited text no. 2
    
3.
Compston A. Genetic epidemiology of multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;62:553-61.  Back to cited text no. 3
    
4.
Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 2004;3:709-18.  Back to cited text no. 4
    
5.
Gale CR, Martyn CN. Migrant studies in multiple sclerosis. Prog Neurobiol 1995;47:425-48.  Back to cited text no. 5
    
6.
Handel AE, Williamson AJ, Disanto G, Dobson R, Giovannoni G, Ramagopalan SV. Smoking and multiple sclerosis: An updated meta-analysis. PLoS One 2011;6:e16149.  Back to cited text no. 6
    
7.
Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62:60-5.  Back to cited text no. 7
    
8.
Haahr S, Plesner AM, Vestergaard BF, Höllsberg P. A role of late Epstein-Barr virus infection in multiple sclerosis. Acta Neurol Scand 2004;109:270-5.  Back to cited text no. 8
    
9.
Etemadifar M, Maghzi AH. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran. Mult Scler 2011;17:1022-7.  Back to cited text no. 9
    
10.
Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, Pakdaman H. Multiple sclerosis in Iran: A demographic study of 8,000 patients and changes over time. Eur Neurol 2010;64:331-6.  Back to cited text no. 10
    
11.
Flachenecker P, Hartung HP. EDMUS – A new European databank for multiple sclerosis. A brief introduction of ongoing and planned multicenter studies within the scope of the “European Concentrated Action for Multiple Sclerosis”. Nervenarzt 1996;67:277-82.  Back to cited text no. 11
    
12.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983;33:1444-52.  Back to cited text no. 12
[PUBMED]    
13.
Warren S, Greenhill S, Warren KG. Emotional stress and the development of multiple sclerosis: Case-control evidence of a relationship. J Chronic Dis 1982;35:821-31.  Back to cited text no. 13
[PUBMED]    
14.
Grant I, Brown GW, Harris T, McDonald WI, Patterson T, Trimble MR. Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis. J Neurol Neurosurg Psychiatry 1989;52:8-13.  Back to cited text no. 14
    
15.
Li J, Johansen C, Brønnum-Hansen H, Stenager E, Koch-Henriksen N, Olsen J. The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark. Neurology 2004;62:726-9.  Back to cited text no. 15
    
16.
Bachmann S, Kesselring J. Multiple sclerosis and infectious childhood diseases. Neuroepidemiology 1998;17:154-60.  Back to cited text no. 16
    
17.
Granieri E, Casetta I, Tola MR, Ferrante P. Multiple sclerosis: Infectious hypothesis. Neurol Sci 2001;22:179-85.  Back to cited text no. 17
    
18.
Poskanzer DC, Sever JL, Sheridan JL, Prenney LB. Multiple sclerosis in the Orkney and Shetland Islands. IV: Viral antibody titres and viral infections. J Epidemiol Community Health 1980;34:258-64.  Back to cited text no. 18
[PUBMED]    
19.
Ahlgren C, Torén K, Odén A, Andersen O. A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk. Eur J Epidemiol 2009;24:541-52.  Back to cited text no. 19
    
20.
Alter M, Zhen-xin Z, Davanipour Z, Sobel E, Min Lai S, LaRue L. Does delay in acquiring childhood infection increase risk of multiple sclerosis? Ital J Neurol Sci 1987;Suppl 6:11-6.  Back to cited text no. 20
    
21.
Hernán MA, Zhang SM, Lipworth L, Olek MJ, Ascherio A. Multiple sclerosis and age at infection with common viruses. Epidemiology 2001;12:301-6.  Back to cited text no. 21
    
22.
Bansil S, Singhal BS, Ahuja GK, Riise T, Ladiwala U, Behari M, et al. Multiple sclerosis in India: A case-control study of environmental exposures. Acta Neurol Scand 1997;95:90-5.  Back to cited text no. 22
    
23.
Bager P, Nielsen NM, Bihrmann K, Frisch M, Hjalgrim H, Wohlfart J, et al. Childhood infections and risk of multiple sclerosis. Brain 2004;127:2491-7.  Back to cited text no. 23
    
24.
Butcher PJ. Milk consumption and multiple sclerosis – An etiological hypothesis. Med Hypotheses 1986;19:169-78.  Back to cited text no. 24
[PUBMED]    
25.
Malosse D, Perron H, Sasco A, Seigneurin JM. Correlation between milk and dairy product consumption and multiple sclerosis prevalence: A worldwide study. Neuroepidemiology 1992;11:304-12.  Back to cited text no. 25
    
26.
Stefferl A, Schubart A, Storch2 M, Amini A, Mather I, Lassmann H, et al. Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. J Immunol 2000;165:2859-65.  Back to cited text no. 26
Advanced Biomedical Research
Volume 2016, june
June 2016
Pages 1-4